Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA)
CUSIP: 640979100
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 186,788,806
- Total 13F shares
- 68,678,182
- Share change
- +660,727
- Total reported value
- $907,013,068
- Put/Call ratio
- 71%
- Price per share
- $13.21
- Number of holders
- 103
- Value change
- +$21,361,695
- Number of buys
- 54
- Number of sells
- 32
Quarterly Holders Quick Answers
What is CUSIP 640979100?
CUSIP 640979100 identifies NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 640979100:
Top shareholders of NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AMGEN INC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
35,368,653
|
$423,716,463 | — | 19 Sep 2023 | |
| FMR LLC |
13F
3/4/5
|
Company · Other* |
4.6%
|
8,622,468
|
$84,758,860 | — | 30 Jun 2024 | |
| SOFTBANK GROUP CORP. |
13F
|
Company |
4.1%
|
7,646,916
|
$75,169,184 | — | 30 Jun 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.7%
|
5,101,096
|
$50,144,000 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.5%
|
4,603,394
|
$45,251,364 | — | 30 Jun 2024 | |
| MIC Capital Management UK LLP |
13F
|
Company |
2.4%
|
4,460,700
|
$43,848,682 | — | 30 Jun 2024 | |
| ICONIQ Capital, LLC |
13F
|
Company |
1.8%
|
3,398,628
|
$33,408,513 | — | 30 Jun 2024 | |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST |
13F
|
Company |
1.8%
|
3,309,123
|
$32,528,679 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
3,274,124
|
$32,184,640 | — | 30 Jun 2024 | |
| Artal Group S.A. |
13F
|
Company |
1.5%
|
2,824,052
|
$27,760,431 | — | 30 Jun 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.1%
|
2,071,450
|
$20,362,354 | — | 30 Jun 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
0.99%
|
1,849,445
|
$18,180,044 | — | 30 Jun 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.96%
|
1,800,000
|
$17,694,000 | — | 30 Jun 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.8%
|
1,500,000
|
$14,745,000 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
1,285,462
|
$12,636,619 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.58%
|
1,083,298
|
$10,648,819 | — | 30 Jun 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.55%
|
1,034,600
|
$10,170,118 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.46%
|
860,443
|
$8,458,155 | — | 30 Jun 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.41%
|
760,007
|
$7,470,869 | — | 30 Jun 2024 | |
| Gosebruch Henry O |
3/4/5
|
President & CEO, Director |
—
mixed-class rows
|
749,793
mixed-class rows
|
$7,065,720 | — | 14 Feb 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.36%
|
669,486
|
$6,582,000 | — | 30 Jun 2024 | |
| Callan Capital, LLC |
13F
|
Company |
0.35%
|
661,194
|
$6,499,537 | — | 30 Jun 2024 | |
| SOROS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.27%
|
508,913
|
$5,002,615 | — | 30 Jun 2024 | |
| Carol Y. Suh |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
544,674
mixed-class rows
|
$4,488,595 | — | 14 Feb 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.21%
|
390,084
|
$3,834,526 | — | 30 Jun 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.2%
|
380,160
|
$3,736,973 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.17%
|
318,457
|
$3,130,433 | — | 30 Jun 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.16%
|
300,000
|
$2,949,000 | — | 30 Jun 2024 | |
| Addis & Hill, Inc |
13F
|
Company |
0.16%
|
300,000
|
$2,940,000 | — | 30 Jun 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
295,973
|
$2,909,415 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
295,657
|
$2,906,308 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
291,364
|
$2,864,108 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.14%
|
267,225
|
$2,626,822 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
235,593
|
$2,315,879 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.12%
|
226,585
|
$2,227,329 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.12%
|
225,732
|
$2,218,946 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.09%
|
172,520
|
$1,695,872 | — | 30 Jun 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.09%
|
168,686
|
$1,658,183 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.09%
|
164,160
|
$1,613,693 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
156,738
|
$1,540,735 | — | 30 Jun 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.08%
|
150,000
|
$1,474,500 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.08%
|
144,994
|
$1,425,291 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
139,637
|
$1,372,631 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.07%
|
134,545
|
$1,322,577 | — | 30 Jun 2024 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.07%
|
124,418
|
$1,223,029 | — | 30 Jun 2024 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.06%
|
114,594
|
$1,126,459 | — | 30 Jun 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.06%
|
111,828
|
$1,099,269 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
0.06%
|
110,000
|
$1,081,300 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
103,258
|
$1,015,016 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.05%
|
87,943
|
$864,480 | — | 30 Jun 2024 |
Institutional Holders of Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA) as of Q3 2024
As of 30 Sep 2024,
Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,678,182 shares.
The largest 10 holders included
FMR LLC, SOFTBANK GROUP CORP., BlackRock, Inc., T. Rowe Price Investment Management, Inc., MIC Capital Management UK LLP, VANGUARD GROUP INC, ICONIQ Capital, LLC, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, Siren, L.L.C., and EcoR1 Capital, LLC.
This page lists
103
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
92
Q3 2024 holders
103
Holder diff
11
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.